Literature DB >> 19641666

Protective effect of Terminalia chebula against lysosomal enzyme alterations in isoproterenol-induced cardiac damage in rats.

Subramaniyan Suchalatha1, Chennam Srinivasulu Shyamala Devi.   

Abstract

BACKGROUND: Terminalia chebula is an ayurvedic drug recommended for the treatment of heart diseases. Earlier studies by the authors validated the beneficial cardioprotective effect of T chebula against isoproterenol-induced myocardial infarction.
OBJECTIVES: To evaluate the therapeutic efficacy of T chebula in protecting against isoproterenol-induced lysosomal membrane damage.
METHODS: Lysosomal enzyme activities from the serum, heart and lysosomal fractions were determined. The triphenyltetrazolium chloride assay was used to confirm the protective effect of T chebula on the myocardium.
RESULTS: Isoproterenol administration produced significant cardiac damage (as seen by the triphenyltetrazolium chloride assay) and significantly altered lysosomal enzyme activities. Pretreatment with an ethanol extract of T chebula was found to retain near normal activities of lysosomal enzymes in rats given T chebula or T chebula plus isoproterenol compared with rats given isoproterenol alone.
CONCLUSIONS: Pretreatment with T chebula extract stabilizes the lysosomal membrane and, thus, may have prevented myocardial damage.

Entities:  

Keywords:  Isoproterenol; Lysosomes; Myocardial injury; Rats; T chebula

Year:  2005        PMID: 19641666      PMCID: PMC2716228     

Source DB:  PubMed          Journal:  Exp Clin Cardiol        ISSN: 1205-6626


  33 in total

1.  Effect of L-arginine and L-lysine on lysosomal hydrolases and membrane bound phosphatases in experimentally induced myocardial infarction in rats.

Authors:  Kesavarao Kumar Ebenezar; Venkatachalem Sathish; Thiruvengadam Devaki
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

2.  Hypolipidemic activity of three indigenous drugs in experimentally induced atherosclerosis.

Authors:  H P Shaila; S L Udupa; A L Udupa
Journal:  Int J Cardiol       Date:  1998-12-01       Impact factor: 4.164

3.  Cathepsin D activity in normal and osteoarthritic human cartilage.

Authors:  A I Sapolsky; R D Altman; D S Howell
Journal:  Fed Proc       Date:  1973-04

4.  Biochemical basis of the protective effect of propranolol pretreatment in experimental myocardial necrosis.

Authors:  M P Gupta; S C Manchanda; S D Seth
Journal:  Indian J Exp Biol       Date:  1982-01       Impact factor: 0.818

5.  Macroscopic enzyme-mapping verification of large, homogeneous, experimental myocardial infarcts of predictable size and location in dogs.

Authors:  J T Lie; P C Pairolero; K E Holley; J L Titus
Journal:  J Thorac Cardiovasc Surg       Date:  1975-04       Impact factor: 5.209

6.  Effect of a novel thromboxane A2 synthetase inhibitor on ischemia-induced mitochondrial dysfunction in canine hearts.

Authors:  T Ogawa; N Hieda; S Sugiyama; Y Toki; T Ito; K Ogawa; T Satake; T Ozawa
Journal:  Arzneimittelforschung       Date:  1988-02

7.  A simple automated colorimetric method for determination of N-acetyl- beta-D-glucosaminidase.

Authors:  J C Moore; J E Morris
Journal:  Ann Clin Biochem       Date:  1982-05       Impact factor: 2.057

8.  [Effect of vitamins A and E on the contractile function of the heart in experimental myocardial infarction].

Authors:  V A Frolov; V A Kapustin
Journal:  Kardiologiia       Date:  1983-07       Impact factor: 0.395

9.  Protective effect of Terminalia chebula against experimental myocardial injury induced by isoproterenol.

Authors:  S Suchalatha; C S Shyamala Devi
Journal:  Indian J Exp Biol       Date:  2004-02       Impact factor: 0.818

Review 10.  Oxygen free radicals and cardiac depression.

Authors:  J Kalra; K Prasad
Journal:  Clin Biochem       Date:  1994-06       Impact factor: 3.281

View more
  5 in total

1.  Therapeutic effect of Saraca asoca (Roxb.) Wilde on lysosomal enzymes and collagen metabolism in adjuvant induced arthritis.

Authors:  Subramanian Saravanan; Narasimhan Prakash Babu; Perumal Pandikumar; Savarimuthu Ignacimuthu
Journal:  Inflammopharmacology       Date:  2011-09-23       Impact factor: 4.473

2.  Extract from Terminalia chebula seeds protect against experimental ischemic neuronal damage via maintaining SODs and BDNF levels.

Authors:  Joon Ha Park; Han Seung Joo; Ki-Yeon Yoo; Bich Na Shin; In Hye Kim; Choong Hyun Lee; Jung Hoon Choi; Kyunghee Byun; Bonghee Lee; Soon Sung Lim; Myong Jo Kim; Moo-Ho Won
Journal:  Neurochem Res       Date:  2011-06-12       Impact factor: 3.996

3.  Potential Antioxidant Role of Tridham in Managing Oxidative Stress against Aflatoxin-B(1)-Induced Experimental Hepatocellular Carcinoma.

Authors:  Vijaya Ravinayagam; Ravindran Jaganathan; Sachdanandam Panchanadham; Shanthi Palanivelu
Journal:  Int J Hepatol       Date:  2012-02-01

Review 4.  A comprehensive review on the diverse pharmacological perspectives of Terminalia chebula Retz.

Authors:  Md Rakibul Hassan Bulbul; Mohammad Nizam Uddin Chowdhury; Taslima Anjum Naima; Saad Ahmed Sami; Md Shakil Imtiaj; Nazmul Huda; Md Giash Uddin
Journal:  Heliyon       Date:  2022-08-14

5.  Terminalia fagifolia Mart. & Zucc. elicits vasorelaxation of rat thoracic aorta through nitric oxide and K+ channels dependent mechanism.

Authors:  Emanuella F de Carvalho; André F Nunes; Náiguel C B Silva; João Paulo da Silva Gomes; Renato P de Sousa; Valdelânia G Silva; Paulo H M Nunes; Rosimeire F Santos; Mariana H Chaves; Aldeidia P Oliveira; Rita C M Oliveira
Journal:  Biol Open       Date:  2019-02-27       Impact factor: 2.422

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.